The curative and mechanistic acumen of curcuminoids formulations against haloperidol induced Parkinson’s disease animal model

[1]  Q. He,et al.  Important changes in germination, seedling tolerance, and active components content due to drought stress on three licorice (Glycyrrhiza) species , 2022, Industrial Crops and Products.

[2]  B. Ahmad,et al.  Antiparkinsonian activity of Cucurbita pepo seeds along with possible underlying mechanism , 2021, Metabolic Brain Disease.

[3]  B. Ahmad,et al.  Appraisal of anti-Parkinson activity of rhinacanthin-C in haloperidol-induced parkinsonism in mice: A mechanistic approach. , 2021, Journal of food biochemistry.

[4]  B. Ahmad,et al.  Screening of Synthetic Isoxazolone Derivative Role in Alzheimer’s Disease: Computational and Pharmacological Approach , 2021, Neurochemical Research.

[5]  B. Ahmad,et al.  Anti-Parkinson’s Activity of Tribulus terrestris via Modulation of AChE, α-Synuclein, TNF-α, and IL-1β , 2020, ACS omega.

[6]  D. G. Parambi,et al.  Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson’s Disease , 2020, Neurochemical Research.

[7]  B. Ahmad,et al.  Investigation of anti-Parkinson activity of dicyclomine , 2020, The International journal of neuroscience.

[8]  B. Ahmad,et al.  In Silico Study and Pharmacological Evaluation of Eplerinone as an Anti-Alzheimer’s Drug in STZ-Induced Alzheimer’s Disease Model , 2020, ACS omega.

[9]  Haixia Chen,et al.  A green method for preparation of curcuminoid-rich Curcuma longa extract and evaluation of its anticancer activity , 2019, Pharmacognosy Magazine.

[10]  M. Hamed,et al.  Optimization of Curcuminoids Extraction for Evaluation Against Parkinson’s Disease in Rats , 2019, Journal of Biologically Active Products from Nature.

[11]  B. Ahmad,et al.  β-Carotene: A Natural Compound Improves Cognitive Impairment and Oxidative Stress in a Mouse Model of Streptozotocin-Induced Alzheimer’s Disease , 2019, Biomolecules.

[12]  B. Ahmad,et al.  Experimental and Computational Studies to Characterize and Evaluate the Therapeutic Effect of Albizia lebbeck (L.) Seeds in Alzheimer’s Disease , 2019, Medicina.

[13]  W. Teo,et al.  Parkinson's Disease and the Environment , 2019, Front. Neurol..

[14]  I. Ishola,et al.  Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation , 2018, Metabolic Brain Disease.

[15]  Alberto J Espay,et al.  Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations , 2018, Movement disorders : official journal of the Movement Disorder Society.

[16]  P. Pal,et al.  Antioxidant, Anti-Alzheimer and Anti-Pparkinson Activity of Artemisia nilagirica Leaves with Flowering Tops , 2018 .

[17]  B. Ahmad,et al.  Acute oral toxicity evaluation of aqueous ethanolic extract of Saccharum munja Roxb. roots in albino mice as per OECD 425 TG , 2017, Toxicology reports.

[18]  Chitra,et al.  EFFECT OF HYDROALCOHOLIC EXTRACT OF ACHYRANTHES ASPERA ON HALOPERIDOLINDUCED PARKINSON’S DISEASE IN WISTAR RATS , 2017 .

[19]  Miao-Xuan Sun,et al.  Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review , 2017, BMC Complementary and Alternative Medicine.

[20]  S. Srivastav,et al.  Important medicinal herbs in Parkinson's disease pharmacotherapy. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  S. Acharya,et al.  Anti-Parkinson Activity of Petroleum Ether Extract of Ficus religiosa (L.) Leaves , 2016, Advances in pharmacological sciences.

[22]  H. Chaves,et al.  Mechanisms Involved in the Anti-Inflammatory Action of a Polysulfated Fraction from Gracilaria cornea in Rats , 2015, PloS one.

[23]  N. Gill,et al.  Neuroprotective Effect of Juniperus communis on Chlorpromazine Induced Parkinson Disease in Animal Model , 2015 .

[24]  M. Sudhakar,et al.  Protective Effect of Selenium Against Aluminum Chloride-Induced Alzheimer’s Disease: Behavioral and Biochemical Alterations in Rats , 2015, Biological Trace Element Research.

[25]  G. Barreto,et al.  Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease , 2015, Front. Aging Neurosci..

[26]  S. Nada,et al.  Effect of Cannabis sativa on oxidative stress and organ damage after systemic endotoxin administration in mice , 2014, Comparative Clinical Pathology.

[27]  D. Dexter,et al.  Parkinson disease: from pathology to molecular disease mechanisms. , 2013, Free radical biology & medicine.

[28]  H. Hirai,et al.  Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease. , 2013, Brain : a journal of neurology.

[29]  R. Deacon.  Measuring Motor Coordination in Mice , 2013, Journal of visualized experiments : JoVE.

[30]  F. Pitossi,et al.  Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease? , 2013, Frontiers in Cellular Neuroscience.

[31]  Dhiman Ghosh,et al.  Curcumin modulates α-synuclein aggregation and toxicity. , 2013, ACS chemical neuroscience.

[32]  W. Geldenhuys,et al.  Curcumin and neurodegenerative diseases: a perspective , 2012, Expert opinion on investigational drugs.

[33]  N. Salem,et al.  Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice , 2012, EXCLI journal.

[34]  B. Aggarwal,et al.  Chemical Composition and Product Quality Control of Turmeric (Curcuma longa L.) , 2011 .

[35]  S. Rajasankar,et al.  Parkinson’s disease: oxidative stress and therapeutic approaches , 2010, Neurological Sciences.

[36]  S. Rajasankar,et al.  Ashwagandha leaf extract: A potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease , 2009, Neuroscience Letters.

[37]  M. Bharath,et al.  Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. , 2008, Free radical biology & medicine.

[38]  Xuejun Zhang,et al.  Acetylcholinesterase and apoptosis , 2008, The FEBS journal.

[39]  T. Ried,et al.  Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage. , 2007, BioTechniques.

[40]  Brian J Cummings,et al.  Adaptation of a ladder beam walking task to assess locomotor recovery in mice following spinal cord injury , 2007, Behavioural Brain Research.

[41]  H. Bergman,et al.  Adaptive acetylcholinesterase splicing patterns attenuate 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinsonism in mice , 2006, The European journal of neuroscience.

[42]  B. Aggarwal,et al.  Curcumin: Getting Back to the Roots , 2005, Annals of the New York Academy of Sciences.

[43]  S. Gould,et al.  2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review , 2005 .

[44]  L. Stanford,et al.  MHC-congenic mice (C57BL/6J and B6-H-2K) show differences in speed but not accuracy in learning the Hebb–Williams Maze , 2003, Behavioural Brain Research.

[45]  G. Miller,et al.  Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism , 2003, Journal of Neuroscience Methods.

[46]  Richard E. Brown,et al.  Differences in Measures of Exploration and Fear in MHC-Congenic C57BL/6J and B6-H-2K Mice , 1999 .

[47]  Karin Klapdor,et al.  A low-cost method to analyse footprint patterns , 1997, Journal of Neuroscience Methods.

[48]  C. Hass,et al.  Lower Extremity Muscle Strength and Force Variability in Persons With Parkinson Disease , 2019, Journal of neurologic physical therapy : JNPT.

[49]  P. Rajeswari,et al.  The effect of Oxalis corniculata extract against the behavioral changes induced by 1-methyl-4-phenyl-1 , 2 , 3 , 6-tetrahydropyridine ( MPTP ) in mice , 2017 .

[50]  R. Marconi,et al.  Treatment Strategies in Early Parkinson's Disease. , 2017, International review of neurobiology.

[51]  Murali M. Yallapu,et al.  Curcumin nanoformulations: a future nanomedicine for cancer. , 2012, Drug discovery today.

[52]  O. Isacson,et al.  Neuroinflammation Mediated by IL-1β Increases Susceptibility of Dopamine Neurons to Degeneration in an Animal Model of Parkinson's Disease , 2008 .

[53]  B. Aggarwal,et al.  Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.

[54]  R. E. Brown,et al.  Effects of subchronic methylphenidate hydrochloride administration on the locomotor and exploratory behavior of prepubertal mice. , 2000, Journal of child and adolescent psychopharmacology.

[55]  P. Sanberg,et al.  The Catalepsy Test , 1996 .

[56]  P. Elliott,et al.  Neuroleptic-induced catalepsy as a model of Parkinson's disease I. Effect of dopaminergic agents , 1990, Journal of neural transmission. Parkinson's disease and dementia section.